Evidence map›Paper›PMID 36697940›Full record

ArticleCommunications chemistry2022

Design of a gold clustering site in an engineered apo-ferritin cage.

Chenlin Lu, Basudev Maity, Xue Peng, Nozomi Ito, Satoshi Abe, Xiang Sheng, Takafumi Ueno, Diannan Lu

Abstract read
In one paragraph

Article in Communications chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Molecular Engineering ofMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chenlin LuDepartment of Chemical Engineering, Tsinghua University, Beijing, 100-084, China.
Basudev MaitySchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, 226-8501, Japan.
Xue PengDepartment of Chemical Engineering, Tsinghua University, Beijing, 100-084, China.
Nozomi ItoSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, 226-8501, Japan.
Satoshi AbeSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, 226-8501, Japan.
Xiang ShengTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, and, National Technology Innovation Center of Synthetic Biology, Tianjin, 300308, China.
Takafumi UenoSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, 226-8501, Japan. tueno@bio.titech.ac.jp.ORCID http://orcid.org/0000-0001-9219-0726
Diannan LuDepartment of Chemical Engineering, Tsinghua University, Beijing, 100-084, China. ludiannan@tsinghua.edu.cn.ORCID http://orcid.org/0000-0001-5993-5626

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Water-soluble and biocompatible protein-protected gold nanoclusters (Au NCs) hold great promise for numerous applications. However, design and precise regulation of their structure at an atomic level remain challenging. Herein, we have engineered and constructed a gold clustering site at the 4-fold symmetric axis channel of the apo-ferritin cage. Using a series of X-ray crystal structures, we evaluated the stepwise accumulation process of Au ions into the cage and the formation of a multinuclear Au cluster in our designed cavity. We also disclosed the role of key residues in the metal accumulation process. X-ray crystal structures in combination with quantum chemical (QC) calculation revealed a unique Au clustering site with up to 12 Au atoms positions in the cavity. Moreover, the structure of the gold nanocluster was precisely tuned by the dosage of the Au precursor. As the gold concentration increases, the number of Au atoms position at the clustering site increases from 8 to 12, and a structural rearrangement was observed at a higher Au concentration. Furthermore, the binding affinity order of the four Au binding sites on apo-ferritin was unveiled with a stepwise increase of Au precursor concentration.

Identifiers

PMID36697940
PMCPMC9814837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.